Neupro is a Transdermal Patch, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Ucb, Inc.. The primary component is Rotigotine.
Product ID | 50474-802_35c1c048-bc3d-4579-b73b-6e77389e81f5 |
NDC | 50474-802 |
Product Type | Human Prescription Drug |
Proprietary Name | Neupro |
Generic Name | Rotigotine |
Dosage Form | Patch, Extended Release |
Route of Administration | TRANSDERMAL |
Marketing Start Date | 2012-04-02 |
Marketing Category | NDA / NDA |
Application Number | NDA021829 |
Labeler Name | UCB, Inc. |
Substance Name | ROTIGOTINE |
Active Ingredient Strength | 2 mg/24h |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2012-04-02 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021829 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2012-04-02 |
Marketing Category | NDA |
Application Number | NDA021829 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2012-04-02 |
Ingredient | Strength |
---|---|
ROTIGOTINE | 2 mg/24h |
SPL SET ID: | 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
50474-801 | Neupro | rotigotine |
50474-802 | Neupro | rotigotine |
50474-803 | Neupro | rotigotine |
50474-804 | Neupro | rotigotine |
50474-805 | Neupro | rotigotine |
50474-806 | Neupro | rotigotine |
50474-808 | Neupro | rotigotine |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
NEUPRO 79069118 3763462 Live/Registered |
UCB Pharma GmbH 2009-02-14 |
NEUPRO 76492893 2836118 Live/Registered |
UCB PHARMA GMBH 2003-02-25 |
NEUPRO 75936415 not registered Dead/Abandoned |
Schwarz Pharma AG 2000-03-06 |